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Abstract
The present study was undertaken to investigate the protection against cytotoxicity 
due to tobacco smoke by Adhatoda vasica and Vasicine. The antioxidant potential of 
AVE was analyzed through in vitro assays. The protective effect of Adhatoda vasica 
extract (AVE) and vasicine were analyzed in TSE treated group through MTT assay 
and microscopic analysis.A dose dependent increase in reducing power of AVE was 
observed. Treatment of A549 & THP-1 cell lines with 1-2 µg/ml (AVE) & 0.01-0.02 
µg/ml (Vasicine) respectively for 3 hrs maintained the cell viability. Approximately 
50% cell death was observed at 2% & 5% TSE on 24 hrs exposure. Pre-treatment of 
cell lines with AVE & Vasicine (2µg/ml & 0.02 µg/ml) respectively could overcome 
the toxic effect of TSE. This study showed that AVE has a great potential in reducing 
the toxic effects of A549 &THP-1 cell lines.
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1 InTRoduCTIon
The rate of tobacco smoking is increasing worldwide, particularly in resource-poor countries (Slama et al., 2008). The deleterious effects of smoking on health are severe and extensive, including impaired lung 
capacity, lung cancer, phlegm, cough, difficulty in breathing, bronchial trouble 
and vesicular emphysema (Hecht, 1999; Vainio et al., 2001). 
Adhatoda vasica has been used to treat respiratory and other allergic 
conditions since years. It has been shown to treat many other diseased 
conditions like diabetes, ulcer etc. Vasicine is the main active ingredient of AV. 
It has also been proven to be a very good anti-inflammatory, anti allergic, and 
anti-ulcer etc. by various scientists (Rachana et al., 2011).
There are several medicinally plants proven to cure respiratory disorder to 
ameliorate this imbalance of oxidants and antioxidants in respiratory disorder. 
Many kinds of medicinal plants, which have been used as foods or medicinal 
purposes for a long time in Asia, are safe and may contain strong antioxidant 
activities.
This study is an attempt to evaluate the extent of toxicity caused by various 
concentrations of tobacco smoke and to check if, AV extract is able to overcome 





Journal of Pharmaceutical Technology, Research and Management (JPTRM), Volume 1, May 2013
the oxidative stress and cell death caused by the tobacco smoke in the human 
alveolar and macrophage cell lines (A549 & THP-1). The safe dose range of 
AVE for both the cell lines were determined by standard protocol. Further, 
the cells were pretreated with various concentrations of AVE (range 1-5µg/
ml) and its active compound (Vasicine) (range 0.01-0.05µg/ml) and were then 
exposed to TSE (conc. 0.5-10%). The results obtained were compared with the 
respective controls to evaluate the modulation brought about with regards to 
cell viability in both the cell lines.
There are various approaches to determine that the biological system has 
undergone “oxidative stress” and because of tobacco smoking and has been 
tabulated in Table 1 (Bashan et al., 2009).
Table 1: Parameters for assessing the “oxidative stress” in biological system
Sl. no. Ways of assessment Parameters of choice
1 Pro-oxidant activity NADPH oxidase, mitochondrial reactive oxygen species 
(ROS)
2 Antioxidant activity Glutathione (GSH), Superoxide dismutase (SOD), 
Glutathione reductase (GR), Catalase, total antioxidant 
activity
3 Redox state of the cell GSH/GSSG ratio
4 Oxidative damage TBARS (thiobarbituric acid reactive substance), 4-HNE 
(4-hydroxynonenal), protein oxidation, DNA oxidation
2 MATeRIAlS And MeThodS
2.1 Preparation of the ethanolic extract of Adhatoda vasica
Adhatoda vasica dried leaf powder was collect from Jeevan, herb, Madhay 
Pardesh. The powdered leaves of A. vasica were exhaustively extracted with 
90% ethanol in a Soxhlet’s apparatus. The ethanolic extracts of A. vasica (AVE) 
thus obtained, were collected and concentrated using rotary evaporator under 
reduced pressure at less than 40°C. Then the extracts were stored in aliquots at 
-80°C (stock) until used for further study. 
2.2 Chemicals 
The principle reagents used in this study and their sources are as follows. 
Ascorbic acid, dimethylsulfoxide (DMSO), penicillin, streptomycin, Nitro 
blue tetrazolium chloride and ABTS (2, 2’-azino-bis (3-ethylbenzthiazoline-
6-sulphonic acid) were purchased from Sigma-Aldrich (St Louis, MO, USA). 
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Sodium carbonate anhydrous, sodium hydroxide, and riboflavin were sourced 
from CDH (New Delhi).Fetal bovine serum (FBS), RPMI-1640 and 3-(4, 
5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) from Himedia, 
Mumbai. All other reagents were of analytical grade. A549 & THP-1 cell line 
was obtained from the National Centre for Cell Science (NCCS) Pune, India.
2 3. Antioxidant Activity Measurement
ABTS (2, 2’-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)  
scavenging activity
The ABTS scavenging activity of A. vasica was determined by the method 
of Brand-Williams et al. 1995. 7 mM ABTS solution and 2.4 mM potassium 
persulphate was added in equal volume and incubated for 12-16 hrs at room 
temperature in the dark. 1 ml of freshly prepared ABTS+ solution was added 
in the resulting mixture. The samples of AVE and standard (BHT) were mixed 
individually with the resulting mixture in 1:1 ratio. After 10 mins of incubation, 
the absorbance was measured at 734 nm. The quenching or inhibition capacity 
of the extract for ABTS∙+ and standard butylated hydroxyltoluene (BHT) was 
calculated. The percentage of scavenging capacity of the extract was calculated 
by the equation.
ABTS radical scavenging activity (%) = [(Abscontrol - Abssample)]/
(Abscontrol)] x 100
where Abscontrol is the absorbance of ABTS radical + methanol; Abssample 
is the absorbance of ABTS radical + sample extract /standard.
2.4 Measurement of superoxide dismutase (Sod) activity
The scavenging activity of superoxide anion was determined by the riboflavin-
NBT assay as adapted from Lai et al., 2008. To determine the SOD activity, 
The test sample (0.1 ml) at different extract concentrations were first mixed 
with 2.9 ml of 20 mM phosphate buffer (pH 7.2) containing 0.2 ml of 0.1 M 
EDTA and 0.1 ml of 1.5 mM NBT. After incubation at 37°C for 10 min, 0.05 
ml of 1.2 mM riboflavin was added. The reaction mixture was illuminated with 
a 25 W light tube for 15 min in a foil-lined box. The microtiter plate reader 
was used to measure the absorbance at 560 nm. Deionized water instead of the 
extract was used as a control along with a sample blank which was evaluated 
by adding water instead of the riboflavin solution. The concentration of protein 
that provides 50% inhibition of the riboflavin mediated reduction of NBT, 
taken as SOD activity, was calculated.
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2.5 Cell treatment & MTT assay
The human alveolar (A549) and macrophage (THP-1) cell lines were cultured 
in RPMI-1640 medium and on attaining 70 - 80% confluency, separately, they 
were seeded in 96-well plate at a density of 5x104 cells (Dypbuky et al, 1994). 
The cells were treated with various percentage strength of tobacco smoke 
extract (TSE) for 24 hrs in order to determine its toxic dose that will lead to 
almost 50% cell death, thus generating enough cellular cytotoxicity. In the 
experiments where AVE and Vasicine were evaluated for its preventive effects, 
the cells were pre-exposed to different concentrations (1– 4 µg/ml) of AVE and 
Vasicine (0.01– 0.04 µg/ml) (prepared as per standard protocol) for 3 hrs. Cell 
viability was determined by MTT assay.
2.6 Microscopic analysis
Cells (1x104) were seeded onto six well plate and grown overnight in RPMI 
1640 media with 10% FBS. Treatments of the cells were given according to 
three experimental sets as mentioned in MTT assay. After treatment, the cells 
were washed with PBS (pH 7.4, 20 mM) and then fixed with methanol. After 
fixing, the cells were again washed with PBS buffer and the plate was observed 
under inverted microscope at 40X without staining.
3 ReSulTS
3.1 ABTS radical scavenging activity of AVe 
In ABTS assay, the plant extract exhibited a dose dependent free radical 
scavenging activity against the stable radical (ABTS •) (Figure 1). The IC
50
 
value of the AVE required to scavenge 50% of ABTS • was 200 µg/ml. 
3.2 Superoxide anion scavenging activity
As shown in the figure 2, AVE at a concentration of 0 – 100 µg/ml has shown 
a dose dependent free radical scavenging activity using NBT Reduction 
method. The 50% inhibition of NBT reduction by the ethanolic extract of AV 
has been found to be 55 µg/ml, as shown in Figure 2. 
3.3 effect of TSe on the viability of A549 and ThP-1 cell lines
While evaluating the toxic effects of TSE, it was seen that 2% and 5% 
concentration can lead to almost 50% cell death in THP-1 & A549 cell lines 
respectively. As shown in Figure (3a & 3b) below, almost 50% cell viability 
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Figure 1: Free radical scavenging activity of AVE through ABTS assay
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Figure 4: Assessment of viability of (A549 & THP-1) cells through MTT 
assay after treatment with various concentrations of AVE. Here con= control, 
AVE= Adhatoda vasica extract.
was retained after exposing the cells to the above two TSE concentrations for 
24 hrs.
3.4 dose optimization for AVe and Vasicine 
As shown in Figure 4(a & b) below, the cells were exposed to various 
concentrations of AVE for a time period of 3 hrs. MTT assay reveals that 1– 2 
µg/ml and 0.01 – 0.02 µg/ml concentrations of AVE and Vasicine were in the 
safe range and they were not causing any harmful effects for the cells. Infect, 
the cell viability was found to be increased (118%, 120 % & 110%, 112%) 
&) with 2 µg/ml & 0.02 µg/ml concentrations of AVE & Vasicine in A549 and 
THP-1 respectively. 
Figure 3 (a & b): Effect of treatment with various concentrations of tobacco 
smoke extract on A549 &THP-1 cell lines (5% and 2% TSE showed  50% 
cell death in A549 &THP-1 cell lines respectevely), Here con= control and 
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3.5 Preventive effect of AVe & Vasicine in TSe-induced toxicity
To check whether AVE can show beneficial effects on tobacco smoke extract 
treated cells, the cells were first exposed to 1– 2 µg/ml (AVE) and 0.01 – 0.02 
µg/ml (Vasicine) followed by treatment with 2% & 5% TSE. As shown in 
figure 5 (a & b) below, the cells which were pre-exposed to AVE were more 
resistant to the toxic effects of TSE. 1 and 2 µg/ml AVE were found to be safe 
concentrations for the same.
3.6 Microscopic analysis
On treating the A549 cells with 5% TSE, significant change in cell shape, 
number, and size were observed under light microscope, as compared to 
control (Figure 6a) cell shrinkage was also observed. But, when the cells were 
pre-treated with AVE followed by 5% TSE, there was a significant increase 
in cell number as compared to TSE treated cells alone, but the cell size was 
almost similar to negative control (Figure 6e and 6f).
4 dISCuSSIon
The polyphenols and polysaccharide that were found to be present in AVE 
has been shown to possess antioxidant, immunomodulatory and antiasthmatic 
properties (Rachana et al., 2011). These phytoconstituents help fight against 
free radicals in the body.
As it has been reported to be a good antioxidant, it might be preventing the 
cell death caused by TSE by its nature. Similarly, its constituents like vasicine 
reported to modulate the antioxidant enzyme activities. There is a possibility 
that these mechanisms are involved in the protective role of AVE, and it is 
further required to specifically evaluate the mechanism of action of AVE and 
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the possible targets that could be ROS, oxidant enzymes and other biomarkers 
of oxidative stress.
Reports show that smoking generates free radicals in quantity enough to 
cause oxidative stress in several tissues including lungs. 
5 ConCluSIon
This study reflects the protective role of AVE in preventing cell death of A549 
& THP-1 cells caused by tobacco smoke extract. Further experimental studies 
are required to analyze the mechanism of action of the constituents of the AVE 
for their protective roles. The plant may thus help prevent or delay the onset of 
complications caused by smoking.
ReFeRenCeS
Bashan, N., Kovsan, J., Kachko, I., Ovadia, H. & Rudich, A. (2009). “Positive and negative regulation 
of insulin signaling by reactive oxygen and nitrogen species.” Physiol Rev.  Vol 89, pp 27-71. 
http://dx.doi.org/10.1152/physrev.00014.2008
Brand-Williams W, Cuvelier ME, Berset C.  (1995). “Use of a radical method to evaluate antioxidant 
activity. Lebensm-Wiss U-Technol . Vol 28, pp 25-30. 
 http://dx.doi.org/10.1016/S0023-6438(95)80008-5
Dypbukt J. M., Ankarcrona M., Burkitt M., Sjoholm A., Strom K., Orrenius S., Nicotera P. (1994). 
“Different prooxidant levels stimulate growth, trigger apoptosis, produce necrosis of insulin-
secreting RINm5F Cells.” J Biol Chem. Vol 269, pp 30553-30560.
Figure 6: Microscopic analysis of A549 cells (a) control (untreated cells) (b) 
treated with 2 µg/ml AVE (c) treated with 0.02 µg/ml Vasicine (d) 5% TSE 
treated (e) 5%TSE treated cells which were pre-treated with 2 µg/ml AVE 
and (f) 5%TSE treated cells which were pre-treated with 0.02 µg/ml Vasicine. 










Journal of Pharmaceutical Technology, Research and Management (JPTRM), Volume 1, May 2013
Faizal P., Suresh S., Satheesh Kumar R., Augusti K. T. (2009).“A study on the hypoglycemic and 
hypolipidemic effects of an ayurvedic drug Rajanyamalakadi in diabetic patients”, Indian J 
Clin Biochem. Vol 24, pp 82-87. http://dx.doi.org/10.1007/s12291-009-0014-1
Hecht,S.S. (1999 ). ‘Tobacco smoke carcinogens and lung cancer”. J .Natl. Cancer Inst. 91: 1194-
1210. http://dx.doi.org/10.1093/jnci/91.14.1194
Vainio, H., E. Weiderpass and P.Kleihues. (2001). “Smoking cessation in cancer prevention”. Toxicol. 
Vol 166, pp 47-52. http://dx.doi.org/10.1016/S0300-483X(01)00445-0
Lai, L.S. Chang, P.C. and Chang C.T. (2008). “Isolation and characterization of superoxide dismutase 
from wheat seedlings”. J Agri and Food Chem, Vol 56: pp 8121–8129.
 http://dx.doi.org/10.1021/jf800859f
Rachana, Basu S, Pant M, Kumar MP, Saluja S. (2011). “Review & Future Perspectives of Using 
Vasicine and Related Compounds”. Indo-Global J Pharm Sci. pp 85-98.
Slama K. (2008). “Global perspective on tobacco control. Part I. The global state of the tobacco 
epidemic”. Int J Tuberc Lung Dis. Vol. 12, pp  3–7.
07JPTRM.indd   117 1/26/2015   2:02:31 PM
